Anti-angiogenic therapy explored for retinblastoma

September 1, 2004

Miami-Results from a preclinical tumor model indicate that anti-angiogenic therapy may offer a useful new approach for the treatment of retinoblastoma, said Timothy G. Murray, MD, at Angiogenesis 2004.